Osamu Yokoyama
Overview
Explore the profile of Osamu Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
1549
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Umezawa K, Isezaki T, Okitsu K, Yokoyama O, Suzuki M, Nishimura Y
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40039271
In the development of brain-computer interfaces (BCIs), precise decoding of motor outputs is crucial. This study presents an enhanced Kalman filter approach that integrates electromyography (EMG) with electrocorticography (ECoG) to...
2.
Nakayama Y, Yokoyama O, Hoshi E, Nishimura Y
Neurosci Res
. 2025 Jan;
PMID: 39848467
The primary motor cortex (M1) is believed to be a cortical center for the execution of limb movements. Although M1 neurons mainly project to the spinal cord on the contralateral...
3.
Umeda T, Yokoyama O, Suzuki M, Kaneshige M, Isa T, Nishimura Y
Sci Adv
. 2024 Dec;
10(51):eadq4194.
PMID: 39693430
Mammals can execute intended limb movements despite the fact that spinal reflexes involuntarily modulate muscle activity. To generate appropriate muscle activity, the cortical descending motor output must coordinate with spinal...
4.
Inamura S, Fukiage Y, Kobayashi H, Tsutsumiuchi M, Seki M, Taga M, et al.
Int J Urol
. 2024 Oct;
32(2):151-157.
PMID: 39441013
Background: α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated...
5.
Yokoyama O, Nishimura Y
Commun Biol
. 2024 Oct;
7(1):1215.
PMID: 39367079
Before selecting a saccadic target, we often acquire partial information about the location of the forthcoming target and preselect a region of visual space even before the target becomes visible....
6.
Kabuto T, Inamura S, Kobayashi H, Zha X, Nagase K, Taga M, et al.
PLoS One
. 2024 Sep;
19(9):e0301883.
PMID: 39292699
Purpose: Bladder dysfunction associated with type 2 diabetes mellitus (T2DM) includes urine storage and voiding disorders. We examined pathological conditions of the bladder wall in a rat T2DM model and...
7.
Takahashi S, Kato K, Yokoyama O, Takei M, Gotoh M
J Urol
. 2024 Jul;
212(2):267-279.
PMID: 38979756
Purpose: We aimed to evaluate the therapeutic efficacy and safety of TAS-303, a highly selective noradrenaline reuptake inhibitor, in Japanese women with stress urinary incontinence (SUI). Materials And Methods: A...
8.
Takahashi S, Kato K, Yokoyama O, Takei M, Gotoh M
J Urol
. 2024 Jul;
212(2):278-279.
PMID: 38979755
No abstract available.
9.
Obara K, Kaneshige M, Suzuki M, Yokoyama O, Tazoe T, Nishimura Y
Front Neurosci
. 2023 Mar;
17:1127095.
PMID: 36960166
The corticospinal tract plays a major role in the control of voluntary limb movements, and its damage impedes voluntary limb control. We investigated the feasibility of closed-loop brain-controlled subdural spinal...
10.
Yoshida M, Gotoh M, Yokoyama O, Kakizaki H, Yamanishi T, Yamaguchi O
World J Urol
. 2022 Oct;
40(11):2799-2805.
PMID: 36205739
Purpose: This multicenter, randomized, double-blind, placebo-controlled phase 2 study evaluated the efficacy and safety of TAC-302, a novel drug that restores neurite outgrowth, in patients with detrusor underactivity (DU) and...